Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 330

The DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.

R-2-hydroxyglutarate attenuates aerobic glycolysis in leukemia by targeting the FTO/m6A/PFKP/LDHB axis

Open access
Qing, Ying, Dong, Lei, Gao, Lei, Li, Chenying, Li, Yangchan, Han, Li, Prince, Emily, Tan, Brandon, Deng, Xiaolan, Wetzel, Collin, Shen, Chao, Gao, Min, Chen, Zhenhua, Li, Wei, Zhang, Bin, Braas, Daniel, ten Hoeve, Johanna, Sanchez, Gerardo Javier, Chen, Huiying, Chan, Lai N., Chen, Chun-Wei, Ann, David, Jiang, Lei, Müschen, Markus, Marcucci, Guido, Plas, David R., Li, Zejuan, Su, Rui, Chen, Jianjun·2021·Molecular Cell

Abstract

SUMMARY R-2-hydroxyglutarate (R-2HG), a metabolite produced by mutant isocitrate dehydrogenases (IDH), was recently reported to exhibit anti-tumor activity. However, its effect on cancer metabolism remains largely elusive. Here, unlike its reported inhibitory effect on ATP synthase in glioma, we show R-2HG mainly attenuates aerobic glycolysis, a hallmark of cancer metabolism, in (R-2HG-sensitive) leukemia cells. Mechanistically, R-2HG abrogates FTO/m6A/YTHDF2-mediated post-transcriptional upregulation of PFKP and LDHB (two critical glycolytic genes) expression, and thereby suppresses aerobic glycolysis. Knockdown of FTO, PFKP, or LDHB recapitulates R-2HG-induced glycolytic inhibition in (R-2HG-sensitive) leukemia cells but not normal CD34+ hematopoietic stem/progenitor cells, and inhibits leukemogenesis in vivo, while their overexpression reverses R-2HG-induced effects. R-2HG also suppresses glycolysis and downregulates FTO/PFKP/LDHB expression in human primary IDH-wildtype AML cells, demonstrating the clinical relevance. Collectively, our study reveals previously unrecognized effects of R-2HG and RNA modification on aerobic glycolysis in leukemia, highlighting the therapeutic potential of targeting cancer epitranscriptomics and metabolism.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.molcel.2020.12.026

Cites

94 of 94 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 94 references

Cited by

See all 330

Metadata

Authors
Qing, Y., Dong, L., Gao, L., Li, C., Li, Y., Han, L., Prince, E., Tan, B., Deng, X., Wetzel, C., Shen, C., Gao, M., Chen, Z., Li, W., Zhang, B., Braas, D., ten Hoeve, J., Sanchez, G. J., Chen, H., Chan, L. N., Chen, C.-W., Ann, D., Jiang, L., Müschen, M., Marcucci, G., Plas, D. R., Li, Z., Su, R., & Chen, J.
Venue
Molecular Cell
Publisher
Elsevier BV
Published
2021-03
Volume
81
Issue
5
Pages
922-939.e9
ISSN
1097-2765 (ISSN-L)
OpenAlex
W3119486198
Cited by
330
References
94
FWCI
21.86
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: R-2-hydroxyglutarate attenuates aerobic glycolysis in leukemia by targeting the FTO/m6A/PFKP/LDHB axis. https://app.cochat.ai/papers/10.1016/j.molcel.2020.12.026
The paper
Qing, Y., Dong, L., Gao, L., Li, C., Li, Y., Han, L., Prince, E., Tan, B., Deng, X., Wetzel, C., Shen, C., Gao, M., Chen, Z., Li, W., Zhang, B., Braas, D., ten Hoeve, J., Sanchez, G. J., Chen, H., . . . Chen, J. (2021). R-2-hydroxyglutarate attenuates aerobic glycolysis in leukemia by targeting the FTO/m6A/PFKP/LDHB axis. Molecular Cell. https://doi.org/10.1016/j.molcel.2020.12.026

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.